Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

BACKGROUND: Pazopanib has shown clinical activity against multiple tumour types and is generally well tolerated. However, isolated elevations in transaminases and bilirubin have been observed. This study examined polymorphisms in molecules involved in pharmacokinetic and pharmacodynamic pathways of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, C-F, Reck, B H, Xue, Z, Huang, L, Baker, K L, Chen, M, Chen, E P, Ellens, H E, Mooser, V E, Cardon, L R, Spraggs, C F, Pandite, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865761/
https://www.ncbi.nlm.nih.gov/pubmed/20389299
http://dx.doi.org/10.1038/sj.bjc.6605653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865761/
https://www.ncbi.nlm.nih.gov/pubmed/20389299
http://dx.doi.org/10.1038/sj.bjc.6605653

Ejemplares similares